vimarsana.com
Home
Live Updates
Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presen
Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presen
Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...
Related Keywords
Montreal ,
Quebec ,
Canada ,
Chicago ,
Illinois ,
United States ,
American ,
Philippe Dubuc ,
Julie Schneiderman ,
Ira Winer ,
Theratechnologie Sudocetaxel Zendusortide ,
Christian Marsolais ,
Linkedin ,
American Society Of Clinical Oncology ,
Professor Of Oncology At Wayne State University ,
Theratechnologies Inc ,
Communications Corporate Affairs ,
Twitter ,
Demonstrates Signs ,
Long Term Efficacy ,
Manageable Safety Profile ,
Clinical Oncology ,
Response Evaluation Criteria ,
Solid Tumors ,
Gynecologic Oncology ,
Trials Multidisciplinary Teams ,
Karmanos Cancer Center ,
Associate Professor ,
Wayne State ,
Senior Vice President ,
Chief Medical Officer ,
Sudocetaxel Zendusortide ,
Fast Track ,
Forward Looking Statements ,
Looking Statements ,
Vice President ,
Chief Financial ,